Skip to main content
NIH funding notice RFA-HL-23-002

ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)

Closed on June 17, 2022.

Posted
January 21, 2022
Close date
June 17, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,287,091 in first-year total cost, median $2,287,091.

Most frequent study sections

  1. Special Emphasis Panel[ZHL1 CSR-Q (J1)]1

Most frequent institutions

  1. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under RFA-HL-23-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)1U01HL168478-01BERNARD, GORDON RAPHAELLINDSELL, CHRISTOPHER J.SELF, WESLEY HVANDERBILT UNIVERSITY MEDICAL CENTER, TN$2,287,091ZHL1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HL-23-002: ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience